GlycoMimetics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell GlycoMimetics and other ETFs, options, and stocks.

About GLYC

GlycoMimetics, Inc. engages in the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. It develops proprietary glycomimetics that inhibit disease related functions of carbohydrates.

CEO

Harout Semerjian

CEOHarout Semerjian

Employees

Employees35

Headquarters

Rockville, Maryland

HeadquartersRockville, Maryland

Founded

2003

Founded2003

Employees

Employees35

GLYC Key Statistics

Market cap

124.07M

Market cap124.07M

Price-Earnings ratio

-3.30

Price-Earnings ratio-3.30

Dividend yield

—

Dividend yield—

Average volume

768.14K

Average volume768.14K

High today

$2.17

High today$2.17

Low today

$1.88

Low today$1.88

Open price

$2.17

Open price$2.17

Volume

1.17M

Volume1.17M

52 Week high

$3.53

52 Week high$3.53

52 Week low

$1.11

52 Week low$1.11

GlycoMimetics

Why Robinhood?

GlycoMimetics, Inc. engages in the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. It develops proprietary glycomimetics that inhibit disease related functions of carbohydrates. Show more

GLYC Key Statistics

GlycoMimetics, Inc. engages in the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. It develops proprietary glycomimetics that inhibit disease related functions of carbohydrates.